Swipe om te navigeren naar een ander artikel
Clinicaltrials.gov Registration NCT0087360.
Little is known about the impact of genetic and environmental risk assessment (GERA) feedback on colorectal cancer (CRC) screening. In a recently completed randomized trial, primary care patients received GERA feedback based on a blood test for genetic polymorphisms and serum folate level (GERA Group) versus usual care (Control Group). Subsequently, participants were offered CRC screening. Among participants who received GERA feedback, being at elevated risk was negatively associated with prospective CRC screening adherence. Secondary analyses of data from this study were performed to identify independent predictors of adherence among participants who received GERA feedback. We obtained baseline survey, follow-up survey, and endpoint medical records data on sociodemographic background, knowledge, psychosocial characteristics, risk status, and adherence for 285 GERA Group participants. Univariate and multivariable analyses were performed to identify predictors of CRC screening adherence. Following a 6-month outcomes observation period, we also conducted two focus groups with GERA Group participants to assess their perceptions of GERA risk feedback and screening. Content analyses of focus group data were evaluated to gain insights into participant response to risk feedback. Overall, half of GERA Group participants adhered to screening within 6 months after randomization. Multivariable analyses showed a statistically significant interaction between race and GERA feedback status relative to screening adherence (p = 0.043). Among participants who received average risk feedback, adherence was comparable among whites (49.7 %) and nonwhites (54.1 %); however, among those at elevated risk, adherence was substantially higher among whites (66.7 %) compared to nonwhites (33.3 %). Focus group findings suggest that whites were more likely than nonwhites to view elevated risk feedback as a prompt to screen. In response to receiving elevated risk feedback, nonwhites were more likely than whites to report feeling anxiety about the likelihood of being diagnosed with CRC. Further research is needed to explore race-related CRC screening differences in response to GERA feedback.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Baier, M., Calonge, N., Cutter, G., McClatchey, M., Schoentgen, S., Hines, S., … Ahnen, D. (2000). Validity of self-reported colorectal cancer screening behavior. Cancer Epidemiology and Biomarkers Prevention, 9, 229–232.
Campbell, W. K., & Sedikides, C. (1999). Self-threat magnifies the self-serving bias: A meta-analytic integration. Review of General Psychology, 3, 22–43. CrossRef
Cella, D., Hughes, C., Peterman, A., Chang, C. H., Peshkin, B. N., Schwartz, M. D., & Lerman, C. (2002). A brief assessment of concerns associated with genetic testing for cancer: The Multidimensional Impact of Cancer Risk Assessment (MICRA) Questionnaire. Health Psychology, 21, 564–572. CrossRefPubMed
Cioffi, D. (1990). Beyond attentional strategies: A cognitive-perceptual model of somatic interpretation. Psychological Bulletin, 109, 25–41. CrossRef
Croyle, R. T., Sun, Y. C., & Hart, M. (1997). Processing risk factor information: Defensive biases in health-related judgments and memory. In K. J. Petrie & J. A. Weinman (Eds.), Perceptions of health and illness (pp. 267–483). New York, NY: Overseas Publishers Association.
Ghazarian, A. A., Simonds, N. I., Bennett, K., Pimentel, C. B., Ellison, G. L., Gillanders, E. M., … Mechanic, L. E. (2013). A review of NCI’s extramural grant portfolio: Identifying opportunities for future research in genes and environment in cancer. Cancer Epidemiology, Biomarkers & Prevention, 22, 501–507.
Giovannucci, E., Stampfer, M. J., Colditz, G. A., Hunder, D. J., Fuchs, C., Rosner, B. A., … Willett, W. C. (1998). Multivitamin use, folate, and colon cancer in women in the Nurses’ Health Study. Annals of Internal Medicine, 129, 517–524.
Hilgart, J., Phelps, C., Bennett, P., Hood, K., Brian, K., & Murray, A. (2010). “I have always believed I was at high risk…” The role of expectation in emotional responses to the receipt of an average, moderate or high cancer genetic risk assessment result: A thematic analysis of free-text questionnaire comments. Familial Cancer, 9, 469–477. CrossRefPubMed
Iselin, M. G., & Addis, M. E. (2003). Effects of perceived etiology on perceived helpfulness of treatments for depression. Cognitive Therapy Research, 27, 2005–2222. CrossRef
Keku, T, Millikan, R., Worley, K., Winkel, S., Eaton, A., Biscocho, L., … Sandler, R. (2002). 5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. Cancer Epidemiology, Biomarkers & Prevention, 11, 1611–1621.
Kennedy, D. A., Stern, S. J., Matok, I., Moretti, M. E., Sarkar, M., Adams-Webber, T., et al. (2012). Folate intake, MTHFR Polymorphisms, and the risk of colorectal cancer: A systematic review and meta-analysis. Journal of Cancer Epidemiology, Article ID 952508.
Kim, Y. I. (1999). Folate and cancer prevention: A new medical application of folate beyond hyperhomocysteinemia and neural tube defects. Nutrition Reviews, 57, 314–321. PubMed
LeMarchand, L. L., Wilkens, L. R., Kolonel, L. N., & Henderson, B. E. (2005). The MTHFR C677T polymorphism and colorectal cancer: The multiethnic cohort study. Cancer Epidemiology, Biomarkers and Prevention, 14, 1198–1203. CrossRef
Ma, J., Stampfer, M. J., Giovannucci, E., Artigas, C., Hunter, D. J., Fuchs, C., … Rozen, R. (1997). Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Research, 57, 1098–1102.
McBride, C. M., Bryan, A. D., Bray, M. S., Swan, G. E., & Green, E. D. (2013). Health behavior change: Can genomics improve behavioral adherence? American Journal of Public Health, 102, 401–405. CrossRef
McCaul, K. D., Thiesse-Duffy, E., & Wilson, P. (1992). Coping with medical diagnosis: The effects of at-risk versus disease labels over time. Journal of Applied Social Psychology, 22, 1340–1355. CrossRef
Myers, R. E., Hyslop, T., Sifri, R., Bittner-Fagan, H, Katurakes, N., Crocroft, J., … Wolf, T. (2008). Tailored navigation in colorectal cancer screening. Medical Care, 46, S123–S131.
Myers, R. E., Jepson, C., Ross, E., Jepson, C., Wolf, T., Balshem, A., … Leventhal, H. (1994). Modeling adherence to colorectal cancer screening. Preventive Medicine, 23, 142–151.
Myers, R. E., Manne, S. L., Wilfond, B., Sifri, R., Ziring, B., Wolf, T., … Weinberg, D. S. (2011). A randomized trial of genetic and environmental risk assessment (GERA) for colorectal cancer risk in primary care: Trial design and baseline findings. Contemporary Clinical Trials, 32, 25–31.
Myers, R. E., Sifri, R., Daskalakis, C., DiCarlo, M., Ramakrishnan Geethakumari, P., Cocroft, J., … Vernon, S. W. (2014). Increasing colon cancer screening in primary care among African Americans. Journal of the National Cancer Institute. doi: 10.1093/jnci/dju344.
Myers, R. E., Sifri, R., Hyslop, T., Rosenthal, M., Vernon, S. W., Cocroft, J., … Wender, R. (2007). A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer, 110, 2083–2091.
Palaniappan, L. P., Maxwell, A. E., Crespi, C. M., Wong, E. C., Shing, J., & Wang, E. J. (2011). Population colorectal cancer screening estimates: Comparing self-report to electronic health record data in California. International Journal of Cancer Research and Prevention, 4, 28540.
Taioli, E., Garza, M. A., Ahn, Y. O., Bishop, D. T., Bost, J., Budai, B., … Little, J. (2009). Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: A HuGE-GSEC review. American Journal of Epidemiology, 15, 1207–1021.
Taylor, S. E., & Brown, J. D. (1998). Illusion and well-being: A social psychology perspective on mental health. Psychological Bulletin, 103, 193–210. CrossRef
Turner, R. M. (1998). Adaptive reasoning for real-world problems: A schema-based approach. New York, NY: Psychology Press.
Vernon, S.W., Bartholomew, L. K., McQueen, A., Bettencourt, J. L., Greisinger, A., Coan, S. P., … Myers, R. E. (2011). A randomized controlled trial of a tailored interactive computer-delivered intervention to promote colorectal cancer screening: Sometimes more is just the same. Annals of Behavioral Medicine, 41, 284–299.
Vernon, S. W., Myers, R. E., & Tilley, B. C. (1997). Development and validation of an instrument to measure factors related to colorectal cancer screening adherence. Cancer Epidemiology, Biomarkers and Prevention, 6, 825–832. PubMed
Weinberg, D. S., Myers, R. E., Keenan, E., Ruth, K., Sifri, R., Ziring, B., … Manne, L. (2014). Gene environment risk assessment and colorectal cancer screening in an average risk population: A randomized controlled trial. Annals of Internal Medicine, 151, 537–545.
- Effects of genetic and environmental risk assessment feedback on colorectal cancer screening adherence
Ronald E. Myers
Sharon L. Manne
David S. Weinberg
- Springer US